Humana (NYSE:HUM) Stock Price Down 2.9% Following Analyst Downgrade

Humana Inc. (NYSE:HUMGet Free Report) traded down 2.9% on Friday after JPMorgan Chase & Co. lowered their price target on the stock from $593.00 to $575.00. JPMorgan Chase & Co. currently has a neutral rating on the stock. Humana traded as low as $496.04 and last traded at $497.79. 792,382 shares changed hands during mid-day trading, a decline of 31% from the average session volume of 1,144,073 shares. The stock had previously closed at $512.91.

Other equities research analysts have also recently issued research reports about the stock. Deutsche Bank Aktiengesellschaft increased their price target on shares of Humana from $468.00 to $628.00 and gave the company a “buy” rating in a research report on Monday, August 7th. upgraded Humana from a “buy” rating to a “strong-buy” rating in a report on Friday, November 3rd. Morgan Stanley lowered their price target on Humana from $637.00 to $624.00 and set an “overweight” rating for the company in a research report on Wednesday, August 30th. TD Cowen reduced their target price on Humana from $616.00 to $613.00 and set an “outperform” rating on the stock in a research note on Tuesday, August 15th. Finally, Royal Bank of Canada raised their price target on Humana from $594.00 to $599.00 and gave the stock an “outperform” rating in a research note on Thursday, November 2nd. Four investment analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $590.28.

Read Our Latest Stock Report on Humana

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Sunbelt Securities Inc. purchased a new position in Humana in the 1st quarter worth about $28,000. WFA of San Diego LLC purchased a new position in shares of Humana during the second quarter valued at approximately $29,000. Gradient Investments LLC lifted its position in Humana by 50.0% during the second quarter. Gradient Investments LLC now owns 69 shares of the insurance provider’s stock valued at $31,000 after purchasing an additional 23 shares during the period. Larson Financial Group LLC grew its position in Humana by 81.0% in the 2nd quarter. Larson Financial Group LLC now owns 76 shares of the insurance provider’s stock worth $34,000 after purchasing an additional 34 shares during the period. Finally, Baystate Wealth Management LLC raised its stake in Humana by 84.1% during the 2nd quarter. Baystate Wealth Management LLC now owns 81 shares of the insurance provider’s stock valued at $37,000 after buying an additional 37 shares during the last quarter. Institutional investors own 91.86% of the company’s stock.

Humana Trading Down 3.0 %

The company has a current ratio of 1.37, a quick ratio of 1.37 and a debt-to-equity ratio of 0.56. The stock has a market capitalization of $61.23 billion, a PE ratio of 20.72, a P/E/G ratio of 1.33 and a beta of 0.61. The stock has a 50 day moving average price of $496.41 and a 200-day moving average price of $486.16.

Humana (NYSE:HUMGet Free Report) last released its quarterly earnings results on Wednesday, November 1st. The insurance provider reported $7.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.15 by $0.63. Humana had a return on equity of 21.03% and a net margin of 2.95%. The business had revenue of $26.42 billion during the quarter, compared to the consensus estimate of $25.57 billion. During the same period in the previous year, the company posted $6.88 EPS. The business’s quarterly revenue was up 15.9% compared to the same quarter last year. Sell-side analysts expect that Humana Inc. will post 28.28 earnings per share for the current year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, December 29th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 0.71%. The ex-dividend date is Thursday, December 28th. Humana’s dividend payout ratio is presently 14.68%.

About Humana

(Get Free Report)

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Articles

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with's FREE daily email newsletter.